BOLT

Bolt Biotherapeutics, Inc.

• TipRanks·23h ago

  JonesTrading Keeps Their Hold Rating on Bolt Biotherapeutics (BOLT)

• TipRanks·03/17 08:50

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• TipRanks·03/13 10:25

  Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027

• Dow Jones·03/13 10:20

  Bolt Biotherapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

• Benzinga·03/13 10:12

  HC Wainwright & Co. Reiterates Buy on Bolt Biotherapeutics, Maintains $7 Price Target

• Reuters·03/12 20:58

  Bolt Biotherapeutics Q4 loss narrows as expenses fall

• TipRanks·03/12 20:31

  Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)

• Reuters·03/12 20:16

  Bolt Biotherapeutics Q4 operating loss narrows 58% to USD 7.1 million on R&D expenses down 57% to USD 5 million

• Dow Jones·03/12 20:06

  *Bolt Biotherapeutics 4Q Loss/Shr $3.84 >BOLT

• Dow Jones·03/12 20:06

  Press Release: Bolt Biotherapeutics Reports -2-

• Dow Jones·03/12 20:06

  Press Release: Bolt Biotherapeutics Reports -3-

• Reuters·03/12 20:05

  BOLT BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

• Reuters·02/24 13:01

  Bolt Biotherapeutics management to participate in TD Cowen 46th Annual Health Care Conference and Leerink Partners Global Healthcare Conference

• Reuters·02/04 21:32

  Sarah Nemec, Senior VP Finance and PAO, Reports Acquisition of Bolt Biotherapeutics Inc. Common Shares

• Reuters·01/22 15:17

  BOLT ENTERS GAMING THROUGH PARTNERSHIP WITH PLAYFINITY